India Stock Market Daily Regulatory Digest — August 06, 2026

05-08-2026

Hero MotoCorp held its 43rd AGM on August 5, 2026, reporting its highest-ever revenue of ₹46,830 crore, EBITDA of ₹6,871 crore, and PAT of ₹5,268 crore for FY2025-26. The company retained its global leadership as the world's largest motorcycle and scooter manufacturer for the 25th consecutive year, with total sales of 6.47 million (65 lakh) units. However, the filing does not provide prior-period comparisons, so performance trends (YoY growth or decline) cannot be assessed from this document alone.

• · The AGM was held via Video Conferencing on August 5, 2026 at 11:30 a.m. and concluded at 1:41 p.m.
• · All resolutions were passed by e-voting, including adoption of financial statements, dividend declaration, re-appointment of directors, and ratification of cost auditors' remuneration.
• · Interim dividend of ₹110 per share and final dividend of ₹75 per share for FY2025-26 were confirmed.
• · Dr. Pawan Munjal was re-appointed as Whole-time Director via a special resolution.
• · The company has strengthened its leadership team with new appointments including CEO Harshavardhan Chitale, CTO Sachin Agrawal, and several other C-level executives.
• · Strategic investments in Ather Energy and Euler Motors were increased, and a collaboration with Zero Motorcycles was highlighted.
• · The company is ranked number 1 in India's Two-Wheeler Industry on the Dow Jones Sustainability Index and recognized among TIME Magazine’s Best Companies in Asia-Pacific 2025.
• · Products received the Red Dot Design Award 2025.
• · No prior-period comparisons are provided in the filing, so YoY growth/decline for revenue, EBITDA, PAT, and sales volume cannot be determined from this document.

06-08-2026

3i Infotech Limited released its Annual Report for FY 2025-26 and announced its 33rd AGM to be held on August 28, 2026 via video conferencing. The company reported revenue of ₹693.3 Crore (down 4.5% YoY from ₹725.8 Crore), but improved profitability with EBITDA of ₹72 Crore (up 53.9% YoY) and PAT of ₹35.1 Crore (up 38.5% YoY), marking the second consecutive profitable year. While the US revenue grew 19.2% YoY to contribute 49% of total revenue, overall revenue declined and the company's voluntary attrition stood at 26.9%.

• · The company's Annual Report received the LACP Vision Awards 2024-25 with a score of 98/100, ranking 35th globally and among the Top 100 Annual Reports worldwide.
• · The company also received the Technical Achievement Award for excellence in annual report theme, design, and presentation.
• · Book closure dates: August 22, 2026 to August 28, 2026 (both days inclusive).
• · Cut-off date for voting eligibility: August 21, 2026.
• · The company has completed six consecutive profitable quarters.
• · Revenue from India contributed 40.8%, US 49.4%, APAC 3.2%, MEA 6.6%, and others 0.2%.
• · Revenue by industry: BFSI 36.5%, Government 5.4%, Manufacturing and FMCG 4.3%, IT 47.8%, Others 6.1%.
• · Revenue by line of business: AAA 71.1%, IS 19.5%, BPS 9.2%, Others 0.2%.
• · The Rights Issue was oversubscribed by 1.47 times.

06-08-2026

All Time Plastics Limited reported Q1FY27 standalone revenue of ₹161.1 Cr, up 2.0% YoY and 10.5% QoQ, with EBITDA of ₹23.0 Cr (margin 14.3%), down 19.9% YoY but up 6.8% QoQ. PAT was ₹12.1 Cr, down 5.5% YoY but up 28.8% QoQ. While revenue and volumes grew sequentially, profitability metrics declined year-over-year due to raw material cost spikes and capacity additions, though management expects margin normalization as cost pass-through completes and utilization improves.

• · Gross profit margin compressed ~240 bps QoQ to 39.5% from 41.9% in Q4FY26.
• · Export revenue share remained stable at 84% in Q1FY27 vs 84% in Q4FY26 and 82% in Q1FY26.
• · Domestic revenue share was 16% in Q1FY27, unchanged from Q4FY26 but down from 18% in Q1FY26.
• · Debt-to-equity increased slightly to 0.14 from 0.13 in Q4FY26.
• · Fixed asset turnover ratio declined due to major capex at Khatalwada plant.
• · ROCE and ROE declined majorly due to issue of equity shares during IPO.
• · The company has placed orders for 14 new machines to add 1,500 tons of incremental capacity in Q4FY27.
• · Bamboo facility machinery expected at Guwahati by mid-August 2026, with commercial contribution anticipated from Q4FY27.
• · The company targets FY27 capacity utilization of approximately 75%.
• · Domestic growth target of 30-35% remains central to diversification strategy.
• · The company is the largest exporter of plastic houseware and plastic furniture from India (Plexconcil India).
• · Manufacturing operations are 100% energy neutral since 2022.
• · Over 25% of plastics products manufactured out of recycled plastics in FY26.
• · The company has a 50+ year operating history and 20+ years of design experience.

06-08-2026

Filatex India reported a steady Q1 FY27 with revenue up 16.3% QoQ to ₹1,145 Cr and PAT up 22.1% QoQ to ₹49.1 Cr. However, sales volume remained flat QoQ at 89,872 MT and declined 7.6% YoY from 97,263 MT, while production also fell 11.5% YoY to 84,075 MT. The company is progressing on a ₹690 Cr capex program and a textile-to-textile chemical recycling venture via subsidiary Ecosis, but near-term headwinds from geopolitical volatility and cautious customer buying persist.

• · Capex program of ~₹690 Cr progressing; 50% of PFI expansion expected by Sep 2026, balance by Oct 2026.
• · Ecosis subsidiary signed MoU with Decathlon for structural trials of recycled polyester; also collaboration with A&E threads for premium industrial applications.
• · GAIL's PTA project at Bangalore near trial production (Aug-Sep 2026); IOCL Paradip PTA expected by Mar 2027; Reliance adding 3.2 MTPA PTA capacity.
• · Management noted that competitor recycling capex per ton is 3x to 5x higher than Filatex's.
• · Import duty on PTA/MEG expired on 30 June 2026; company says it has been able to pass on cost changes to customers.
• · Geopolitical risks: Strait of Hormuz disruptions, US-Iran tensions, volatile crude and petrochemical feedstock prices.

06-08-2026

Karur Vysya Bank held its 107th AGM on 5 August 2026 via VC/OAVM, where shareholders adopted the audited financials for FY2025-26, declared a dividend of ₹2.60 per share, and reappointed directors and auditors. The MD & CEO outlined strategic initiatives including AI deployment, sector-focused lending, credit card relaunch, and a ₹29.68 Cr investment for a 16.4% stake in NBFC Sahayya Finserve. The meeting saw 18 shareholder speakers, and all resolutions were passed with no qualifications in the audit reports.

• · AGM held via VC/OAVM on NSDL platform
• · Audited financials for FY ended 31 March 2026 adopted with no qualifications
• · Dividend of ₹2.60 per equity share declared for FY 2025-26
• · Shri B Sankar reappointed as director retiring by rotation
• · M/s Kalyaniwalla & Mistry LLP and M/s Varma & Varma reappointed as Joint Statutory Central Auditors for third year
• · Branch auditors appointed
• · Remote e-voting closed at 5:00 PM on 4 August 2026; e-voting at AGM available until 15 minutes after conclusion
• · Voting results to be announced within two working days on NSE/BSE and bank website
• · Meeting concluded at 2:18 PM

06-08-2026

Sinclairs Hotels Limited reported a 28.4% YoY increase in revenue from operations to ₹2,014.84 Lakh for the quarter ended June 30, 2026, with net profit rising 27.9% YoY to ₹790.99 Lakh. However, sequentially (QoQ), revenue grew 20.2% from a loss-making quarter (March 2026 net loss of ₹85.98 Lakh), indicating a strong seasonal recovery. The Board also approved a dividend of ₹0.80 per share and set September 8, 2026 as the record date, while noting the termination of the lease for Sinclairs Udaipur effective June 30, 2026.

• · The Board approved holding the 54th Annual General Meeting on September 15, 2026 via video conferencing.
• · Record date for dividend eligibility is September 8, 2026; dividend payment on or before October 13, 2026.
• · The lease agreement for Sinclairs Udaipur was terminated effective June 30, 2026.
• · Other income for Q1 FY27 was ₹455.46 Lakh, compared to ₹379.49 Lakh in Q1 FY26 (up 20.0% YoY).
• · Total expenses increased 24.8% YoY to ₹1,453.35 Lakh, driven by higher employee costs (+8.1% YoY) and other expenses (+38.5% YoY).
• · Finance costs rose 52.7% YoY to ₹78.15 Lakh, primarily due to interest on lease liabilities.
• · Depreciation and amortization increased 43.6% YoY to ₹199.48 Lakh.
• · The company has no reportable segments other than hotels and no investments in subsidiaries/associates/joint ventures.

06-08-2026

Tenneco Clean Air India reported strong Q1 FY2027 results with Value-Added Revenue (VAR) growing 18.4% YoY to ₹13,816 million, outpacing industry volume growth of 16.2%. EBITDA increased 7.9% YoY to ₹2,469 million with a resilient margin of 17.9% on VAR, despite commodity cost headwinds and incremental public company costs. However, PAT declined 1.7% YoY to ₹1,652 million, though the company notes this was due to a one-time benefit from the Motocare sale in the prior year; excluding that, PAT growth would have been similar to EBITDA growth.

• · VAR grew 18.4% YoY vs industry volume growth of 16.2%, indicating market share gains.
• · FY2026 value market share: CV Clean Air Solutions 58% (+1% YoY), PV shock absorbers and struts 55% (+3% YoY), off-highway Clean Air Solutions sustained at 68%.
• · ART segment added 4 new customers in Q1 FY2027 and expanded DCx Da Vinci footprint with multiple new application wins.
• · Introduced DCx32 variant targeting smaller vehicles (32mm bore).
• · Secured a strategic spark plug order from India's leading passenger vehicle OEM.
• · Won new program nominations for hot-end, cold-end, and pipe assembly applications from leading OEMs.
• · ART secured maiden order from a leading European ATV manufacturer (new whitespace).
• · Won a heat shield order from Tenneco America (export market).
• · Received Innovation and Performance Award from Mahindra, Ride Performance Award 2026 from ET Auto Tech, and Technology & Innovation Award from DICV.
• · ROCE for FY2026 stood at 94%.
• · EBITDA margin declined 175 bps YoY to 17.9% on VAR due to commodity escalation and public company costs.
• · PAT margin declined 245 bps YoY to 12.0% on VAR.

06-08-2026

TTK Healthcare reported a strong 13.7% YoY increase in revenue from operations to ₹25,755.76 lakh for Q1 FY27, driven by a 63.6% surge in the Protective Devices segment. Net profit after tax rose 63.7% YoY to ₹2,127.92 lakh. However, the Consumer Products segment saw a sharp decline in segment profit, falling 55.0% YoY to ₹284.44 lakh, and the company also recorded an exceptional income reversal of ₹350.42 lakh from a prior-year GST refund.

• · The company has entered into definitive agreements to sell EVA and Good Home Brands to Wipro Enterprises for ₹256 crore, expected to close by September 30, 2026.
• · Protective Devices segment profit swung from a loss of ₹544.34 lakh in Q1 FY26 to a profit of ₹613.20 lakh in Q1 FY27.
• · Consumer Products segment profit more than doubled YoY to ₹284.44 lakh, but was down 46.2% sequentially from ₹528.78 lakh in Q4 FY26.
• · Medical Devices segment profit declined 6.1% YoY to ₹758.02 lakh.
• · Animal Welfare segment profit fell 50.8% YoY to ₹115.13 lakh.
• · Total assets increased to ₹1,38,992.84 lakh as of June 30, 2026, from ₹1,32,874.25 lakh at March 31, 2026.
• · Total liabilities rose to ₹25,044.66 lakh from ₹21,389.21 lakh over the same period.
• · Basic EPS for continuing operations was ₹15.06 for Q1 FY27, up from ₹9.20 in Q1 FY26.

06-08-2026

Edelweiss Financial Services reported a strong 83% YoY increase in consolidated PAT (post MI) to INR 122 Cr for Q1 FY27, with revenue at INR 2,419 Cr. The company also announced plans to raise up to INR 1,000 Cr via public issue of Non-convertible Debentures. However, while the overall results were robust, the wholesale book was reduced to INR 600 Cr, and the Housing Finance GNPA stood at 2.91%.

• · The Board meeting commenced at 11:00 AM and concluded at 1:00 PM.
• · Auditors M/s. Nangia & Co. LLP issued an unmodified opinion on the results.
• · The company plans to raise funds via public issue of Non-convertible Debentures for an amount not exceeding INR 1,000 Cr.
• · The company's customer base grew 30% YoY to over 14 million, with customer assets up 23% YoY to INR 2.8 Tn.
• · Capital adequacy across credit entities is over 27%.
• · The Mutual Fund AUM crossed the milestone of INR 1 Tn in July 2026.
• · The wholesale book was reduced to INR 600 Cr from a peak of INR 18,000 Cr in March 2019.
• · Housing Finance GNPA stood at 2.91% and NNPA at 2.37%.
• · Life Insurance Par and Non-Par products constituted 77% of new business premium in the quarter.

06-08-2026

The filing is a SAST disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011, received by the Exchange on August 06, 2026, from OSM Investment & Trading Co Ltd regarding Chambal Fertilizers & Chemicals Ltd. The filing does not specify the transaction type (acquisition/disposal), volume, value, or the resulting shareholding change. The sector is incorrectly tagged as 'technology' in the query; the company is in the fertilizers/agrochemicals sector. The disclosure is timely but lacks critical quantitative details for a comprehensive analysis.

• · The filing is under Regulation 29(2) of SEBI SAST Regulations, which requires disclosure when a person holding >=5% shares acquires or disposes shares exceeding certain thresholds (typically 2% or more of voting rights).
• · The disclosing entity is OSM Investment & Trading Co Ltd, which is likely a promoter group entity or a substantial shareholder.
• · The sector is incorrectly stated as 'technology' in the query; Chambal Fertilizers is in the fertilizers and chemicals sector (agrochemicals).
• · No transaction details (buy/sell, volume, price, value) are provided in the filing summary.

06-08-2026

Standard Engineering Technology Limited (formerly Standard Glass Lining Technology Limited) reported consolidated revenue from operations of ₹24,769.21 Lakh for Q1 FY27 (quarter ended June 30, 2026), a 43.1% increase YoY from ₹17,307.40 Lakh in Q1 FY26. Profit after tax rose to ₹2,674.62 Lakh from ₹2,113.28 Lakh, up 26.6% YoY. However, other income declined 11.8% YoY to ₹449.80 Lakh. The Board also approved the reappointment of statutory auditors M S K A & Associates LLP for a second term of five years, and fixed the 14th AGM for September 18, 2026.

• · The Board approved the reappointment of M/s. M S K A & Associates LLP as Statutory Auditors for a second term of five consecutive years, from FY 2026-27 to FY 2030-31, subject to shareholder approval.
• · The 14th Annual General Meeting is scheduled for Friday, September 18, 2026 at 11:00 AM IST.
• · The Register of Members and Share Transfer Books will remain closed from September 15, 2026 to September 17, 2026 (both days inclusive), with a record date of September 11, 2026.
• · M/s. RPR & Associates has been appointed as Scrutinizer for remote e-voting and voting at the AGM.
• · The consolidated results include eight subsidiaries, of which six were not reviewed by the principal auditor; their combined revenues were ₹3,389.57 Lakh, net profit ₹165.97 Lakh, and total comprehensive income ₹162.23 Lakh for the quarter.
• · The Board meeting commenced at 12:45 AM and concluded at 1:30 PM on August 06, 2026.

06-08-2026

BirlaNu Limited reported consolidated revenue from operations of ₹117,402 Lakh for Q1 FY27 (quarter ended June 30, 2026), up 11.6% YoY from ₹105,228 Lakh in Q1 FY26. However, the company posted a modest consolidated profit after tax of ₹940 Lakh, compared to a loss of ₹132 Lakh in the same quarter last year. On a standalone basis, revenue grew 10.0% YoY to ₹82,432 Lakh, while profit after tax surged to ₹4,969 Lakh from ₹1,968 Lakh, though the prior-year quarter was restated for an amalgamation. The company is pursuing the amalgamation of Clean Coats Private Limited, with NCLT hearings scheduled, and has completed the amalgamation of five other entities effective April 2024.

• · Consolidated segment revenue: Roofs ₹51,650 Lakh (up 16.9% YoY), Walls ₹15,636 Lakh (up 13.6% YoY), Pipes & Construction chemicals ₹15,910 Lakh (down 5.0% YoY), Floors ₹34,128 Lakh (up 12.1% YoY), Others ₹175 Lakh.
• · Consolidated segment profit/(loss) before tax: Roofs ₹8,968 Lakh, Walls ₹845 Lakh, Pipes & Construction chemicals (₹534 Lakh) loss, Floors (₹3,741 Lakh) loss, Others ₹68 Lakh.
• · Consolidated total comprehensive income for Q1 FY27 was ₹777 Lakh, compared to ₹2,166 Lakh in Q1 FY26 (down 64.1% YoY).
• · Standalone total comprehensive income for Q1 FY27 was ₹4,969 Lakh, compared to ₹1,968 Lakh in Q1 FY26 (up 152.5% YoY).
• · The amalgamation of five transferor companies (Crestia Polytech, Topline Industries, Aditya Poly Industries, Aditya Polytechnic, Prabhu Sainath Polymers) was approved by NCLT Kolkata on 10 March 2026 and became effective from 5 April 2024.
• · The proposed amalgamation of Clean Coats Private Limited with BirlaNu Limited is pending NCLT sanction; Hyderabad Bench hearing on 13 August 2026, Mumbai Bench final hearing on 1 October 2026.
• · Investment in Supercor Industries Limited, Nigeria, remains fully provided for at INR Nil, with a provision of INR 143 Lakh.
• · Auditor's limited review report notes that six subsidiaries' financial results (total revenues ₹34,167.15 Lakh, net loss ₹3,961.19 Lakh) were reviewed by other auditors, and one subsidiary (revenues ₹933.26 Lakh, net profit ₹11.93 Lakh) and the joint venture (share of loss ₹0.48 Lakh) were not reviewed.
• · Consolidated EPS (basic and diluted) for Q1 FY27: ₹12.47, compared to (₹1.75) in Q1 FY26.
• · Standalone EPS (basic and diluted) for Q1 FY27: ₹65.89, compared to ₹26.10 in Q1 FY26.

06-08-2026

RateGain Travel Technologies reported robust Q1 FY2027 results with operating revenue of INR 785.0 Cr (up 187.6% YoY), adjusted EBITDA of INR 193.4 Cr (up 289.3% YoY, margin 24.6%), and adjusted PAT of INR 116.8 Cr (up 148.8% YoY, margin 14.9%). The strong growth was driven by the Sojern acquisition and product innovation, with a 47.3% YoY increase in employee headcount to 1,261. However, the LTV-to-CAC ratio declined to 10.7x from 14.5x in Q1 FY2026, and the Distribution segment grew only 3.1% YoY, indicating mixed performance across business lines.

• · Gross Revenue Retention (GRR) for Q1 FY2027 was 95.6%, up from 94.2% in FY2024.
• · Net Revenue Retention (NRR) for Q1 FY2027 was 106.8%, down from 120.9% in FY2024.
• · Client count increased to 14,158 from 13,410 in FY2026.
• · Revenue by geography: North America 46.7%, Asia Pacific 33.5%, Europe 13.9%, Others 5.9%.
• · Revenue by industry: Hospitality 79.1%, DMOs 7.3%, OTAs 7.3%, Airlines 2.5%, Car Rentals 2.1%, Others 1.7%.
• · Revenue by engagement: Subscription 66.2%, Transaction 20.5%, Hybrid 10.8%, Others 2.5%.
• · Revenue by customers: Top 1-10 accounted for 17.6%, Others 82.4%.
• · Attrition rate for Q1 FY2027 was 14.0%.
• · RateGain won 'Best Company in AI-Powered Travel Marketing' award for the third consecutive year.
• · RateGain was named 'Emerging Company of the Year' at The Economic Times Awards for Corporate Excellence.

06-08-2026

Emcure Pharmaceuticals reported consolidated revenue from operations of ₹25,804.47 million for Q1 FY27 (quarter ended June 30, 2026), up 22.8% YoY from ₹21,005.37 million in Q1 FY26. Consolidated profit after tax rose 36.2% YoY to ₹2,924.93 million from ₹2,147.93 million. However, standalone revenue grew 32.3% YoY to ₹14,509.31 million, while standalone PAT increased 63.0% YoY to ₹2,001.08 million. Sequentially, consolidated revenue grew 4.5% QoQ, but standalone revenue declined 1.1% QoQ.

• · Consolidated revenue from operations for Q1 FY27 was ₹25,804.47 million, compared to ₹24,697.03 million in Q4 FY26 (sequential growth of 4.5%).
• · Consolidated PAT for Q1 FY27 was ₹2,924.93 million, compared to ₹2,437.36 million in Q4 FY26 (sequential growth of 20.0%).
• · Standalone revenue from operations for Q1 FY27 was ₹14,509.31 million, compared to ₹14,677.03 million in Q4 FY26 (sequential decline of 1.1%).
• · Standalone PAT for Q1 FY27 was ₹2,001.08 million, compared to ₹2,336.97 million in Q4 FY26 (sequential decline of 14.4%).
• · Consolidated other income declined to ₹20.71 million in Q1 FY27 from ₹39.92 million in Q4 FY26 and ₹36.96 million in Q1 FY26.
• · Consolidated finance costs decreased to ₹315.36 million in Q1 FY27 from ₹464.01 million in Q4 FY26, but increased from ₹267.55 million in Q1 FY26.
• · Consolidated net gain on foreign currency transactions was ₹228.93 million in Q1 FY27, compared to ₹369.41 million in Q4 FY26 and ₹128.83 million in Q1 FY26.
• · Consolidated changes in fair value of contingent consideration was a gain of ₹16.06 million in Q1 FY27, versus a loss of ₹428.64 million in Q4 FY26 and nil in Q1 FY26.
• · Consolidated exceptional items were nil in Q1 FY27, compared to a loss of ₹103.01 million in Q4 FY26 and a gain of ₹35.00 million in Q1 FY26.
• · Consolidated total comprehensive income for Q1 FY27 was ₹3,131.64 million, up from ₹2,943.67 million in Q1 FY26.
• · Consolidated profit attributable to owners of the holding company was ₹2,939.80 million in Q1 FY27, up from ₹2,069.53 million in Q1 FY26.
• · Consolidated non-controlling interests were a loss of ₹14.87 million in Q1 FY27, versus a gain of ₹78.40 million in Q1 FY26.
• · Standalone other income increased to ₹250.32 million in Q1 FY27 from ₹215.24 million in Q1 FY26.
• · Standalone finance costs increased to ₹327.76 million in Q1 FY27 from ₹205.38 million in Q1 FY26.
• · Standalone net gain on foreign currency transactions was ₹275.30 million in Q1 FY27, versus ₹67.21 million in Q1 FY26.
• · Standalone exceptional items were nil in Q1 FY27, compared to a gain of ₹35.00 million in Q1 FY26.
• · Standalone total comprehensive income for Q1 FY27 was ₹1,999.95 million, up from ₹1,225.65 million in Q1 FY26.
• · Consolidated paid-up equity share capital stood at ₹1,896.82 million as of June 30, 2026, with face value of ₹10 per share.
• · Standalone paid-up equity share capital stood at ₹1,896.80 million as of June 30, 2026.

06-08-2026

Trent Limited reported strong standalone revenue growth of 18.5% YoY to ₹5,666.30 Cr for Q1 FY27 (quarter ended June 30, 2026), with net profit up 25.8% YoY to ₹531.77 Cr. Consolidated revenue grew 17.8% YoY to ₹5,754.71 Cr, while consolidated net profit rose 22.0% YoY to ₹518.07 Cr. However, the company's share of profit from associates/joint ventures turned negative at ₹(9.74) Cr vs. a positive ₹9.21 Cr in the same quarter last year, and the consolidated operating margin (12.92% standalone) showed a slight sequential decline from 11.52% to 12.92% (improved from 11.88% YoY). The board also approved a bonus share issuance (1:2), changes in senior management, and recommended appointment of new statutory auditors.

• · Standalone revenue for Q1 FY27 was ₹5,666.30 Cr vs ₹4,936.64 Cr in Q4 FY26 (sequential growth of 14.8%).
• · Standalone net profit for Q1 FY27 was ₹531.77 Cr vs ₹454.75 Cr in Q4 FY26 (sequential growth of 16.9%).
• · Consolidated revenue for Q1 FY27 was ₹5,754.71 Cr vs ₹5,027.99 Cr in Q4 FY26 (sequential growth of 14.5%).
• · Consolidated net profit for Q1 FY27 was ₹518.07 Cr vs ₹413.10 Cr in Q4 FY26 (sequential growth of 25.4%).
• · Standalone operating margin improved to 12.92% from 11.52% sequentially and 11.88% YoY.
• · Standalone net profit margin declined to 9.38% from 9.99% YoY.
• · Consolidated share of profit from associates/JVs turned negative to ₹(9.74) Cr from positive ₹9.21 Cr YoY.
• · Bonus shares issued in the quarter: 1 bonus share for every 2 shares held.
• · Paid-up equity share capital increased to ₹53.32 Cr from ₹35.55 Cr due to bonus issue.
• · Debt equity ratio improved to 0.29 from 0.34 sequentially.
• · Current ratio declined to 2.23 from 2.57 sequentially.
• · Inventory turnover ratio remained stable at 5.35 vs 5.37 sequentially.
• · Debtors turnover ratio declined to 303.76 from 402.38 sequentially.
• · Exceptional item of ₹25.79 Cr in FY26 related to labour code consolidation.
• · Statutory auditors Deloitte Haskins & Sells LLP to retire after 75th AGM in 2027; B S R & Co. LLP recommended as replacement for 5-year term (FY28-FY32).
• · Head of Internal Audit Mr. Ratul Neogi retiring effective Sept 1, 2026; Ms. Varsha Agarwal appointed as replacement.

06-08-2026

Sudarshan Chemical Industries Limited has communicated to shareholders regarding Tax Deduction at Source (TDS) on the recommended final dividend of ₹5.00 per equity share (250% on face value of ₹2) for FY 2025-26, subject to shareholder approval at the 75th AGM on 18th August 2026. The record date for dividend eligibility is 11th August 2026, with payment scheduled on or before 8th September 2026. The filing details TDS rates and documentation requirements for resident and non-resident shareholders, including higher TDS of 20% for non-residents and 20% for residents without valid PAN.

• · Record date for dividend eligibility: 11th August 2026.
• · Dividend payment date: on or before 8th September 2026.
• · Shareholders must update PAN, residential status, and bank account details before the record date to avoid higher TDS or payment delays.
• · Non-resident shareholders can avail lower DTAA rate by submitting Tax Residency Certificate and other documents.
• · TDS certificates will be emailed after filing TDS return; tax credit can be viewed in Form 168 on TRACES.
• · SEBI mandates electronic dividend payment only; physical warrants/cheques eliminated from 1st April 2024.

06-08-2026

Divi's Laboratories reported a strong Q1 FY27 with consolidated total income rising 24.3% YoY to ₹3,144 crore and profit after tax surging 65.5% to ₹902 crore, driven by robust Custom Synthesis (60% of revenue) and a 19.2% increase in nutraceutical sales to ₹298 crore. However, the operating environment remained challenging with elevated solvent costs, geopolitical uncertainty in West Asia, and a net forex loss of ₹7 crore versus a gain of ₹39 crore a year ago, while the Generics segment saw stable volumes but continued competitive pricing pressure.

• · Custom Synthesis contributed 60% of revenue, Generics 40%.
• · Europe and North America accounted for 75% of exports.
• · Net material consumption was 31.2% of standalone revenue.
• · Cash and cash equivalents stood at ₹3,611 crore; trade receivables ₹3,056 crore; inventory ₹4,413 crore.
• · Capital work in progress was ₹2,034 crore as of June 30, 2026.
• · Three major capex programmes are nearing completion with validations ongoing.
• · Unit 3 is supporting backward integration and phased transfer of manufacturing activities.
• · CSR programs reached over 1.8 million beneficiaries in Andhra Pradesh and Telangana.
• · Geopolitical situation in West Asia introduced additional supply chain uncertainty.
• · Freight rates remained elevated; port congestion and extended transit times increased logistics complexity.

06-08-2026

TAAL Tech Limited (formerly TAAL Enterprises) announced its unaudited financial results for the quarter ended June 30, 2026, and approved a 1:5 stock split (face value from ₹10 to ₹2 per share) to improve liquidity and affordability. The board also re-appointed Ms. Deepa Mathur as Woman Independent Director for a second term, appointed Mr. Muralidhar Chitteti Reddy as an Additional Independent Director, and recommended the re-appointment of M/s TLB & Co. as statutory auditors. No financial figures or period-over-period comparisons were provided in the filing, so performance trends cannot be assessed.

• · The stock split ratio is 1:5, reducing face value from ₹10 to ₹2 per share.
• · Authorized share capital remains unchanged at ₹6,00,00,000; issued, subscribed and paid-up capital remains ₹3,11,63,420.
• · Ms. Deepa Mathur's second term as Independent Director runs from September 2, 2026 to September 2, 2031.
• · Mr. Muralidhar Chitteti Reddy holds a degree in Mechanical Engineering from Osmania University and is an IIM Ahmedabad graduate with 46+ years of experience.
• · M/s TLB & Co. are proposed to be re-appointed as statutory auditors for a second term of four years from the 12th AGM to the 16th AGM (2030).
• · The board meeting started at 12:00 p.m. and concluded at 1:00 p.m. on August 6, 2026.

06-08-2026

TCI Express Limited reported Q1 FY27 standalone revenue from operations of ₹311.95 Cr, up 8.8% YoY from ₹286.75 Cr in Q1 FY26, and net profit of ₹22.38 Cr, up 6.4% YoY from ₹21.04 Cr. On a consolidated basis, revenue grew 9.3% YoY to ₹313.40 Cr, while net profit rose 5.2% to ₹20.49 Cr. However, sequentially (vs Q4 FY26), standalone revenue declined 4.6% and net profit fell 2.9%, indicating a seasonal slowdown. The company also faces a material GST demand of ₹51.36 Cr, which is under appeal.

• · The Board reconstituted its committees (Nomination & Remuneration, Audit, Stakeholders' Relationship, Risk Management) following proposed changes in Board composition.
• · Standalone basic EPS for Q1 FY27 was ₹5.69 (vs ₹5.55 in Q1 FY26); diluted EPS was ₹5.68 (vs ₹5.54).
• · Consolidated basic EPS for Q1 FY27 was ₹5.20 (vs ₹5.13 in Q1 FY26); diluted EPS was ₹5.19 (vs ₹5.12).
• · The company's subsidiaries include TCI Express Pte Limited and TCI Global (Singapore) Pte. Limited (effective 26 Jan 2026).
• · The GST demand of ₹51.36 Cr (plus interest and penalty) relates to non-payment of GST under reverse charge on GTA supplies for the period July 2017 to March 2022; the company has appealed to GSTAT, Haryana after the Commissioner (Appeals) rejected its earlier appeal.

06-08-2026

Nazara Technologies' Board approved a preferential issue of up to 2,39,70,676 equity shares at ₹306 per share, aggregating up to ₹7,33,50,26,856, to six identified investors including incoming CEO Raymond Albaladejo Stauffer. The Board also approved increasing authorized share capital from ₹80,00,00,000 to ₹90,00,00,000 and convening an EGM on August 30, 2026, for shareholder approvals. The filing does not contain any period-over-period financial performance data, so no comparative metrics are available.

• · The Board meeting commenced at 12:50 p.m. and concluded at 01:40 p.m. on August 06, 2026.
• · The relevant date for determining the floor price under SEBI ICDR Regulations is July 31, 2026.
• · The EGM is scheduled for Sunday, August 30, 2026, via video conferencing.
• · The incoming CEO, Raymond Albaladejo Stauffer, will be allotted 1,90,67,969 shares (4.67% post-issue stake) and his appointment is effective September 01, 2026, subject to regulatory approvals.
• · The authorized share capital increase involves creating an additional 5,00,00,000 equity shares of ₹2 each.
• · No cancellation or termination of the proposal for issuance of securities was reported.

06-08-2026

Vikram Kamats Hospitality Limited has filed its 19th Annual Report for FY 2025-26 and convened the 19th Annual General Meeting on August 31, 2026 via video conferencing. Key business includes adoption of financial statements, re-appointment of Dr. Vikram V. Kamat as Managing Director for three years from October 7, 2026, and approval of a material related party transaction involving loans up to ₹40,00,00,000 (₹40 Crore) to its subsidiary Vitizen Hotels Limited. The filing does not disclose financial performance metrics, so no period-over-period comparisons are available.

• · 19th Annual General Meeting scheduled for Monday, 31st August 2026 at 12:00 Noon via VC/OAVM.
• · Remote e-voting period: Friday, 28th August 2026 (09:00 AM) to Sunday, 30th August 2026 (05:00 PM).
• · Record date (cut-off date) for voting: Monday, 24th August 2026.
• · Dr. Vikram V. Kamat to be re-appointed as Managing Director for 3 years from 7th October 2026 to 6th October 2029.
• · Special resolution to approve material related party transaction: loans up to ₹40,00,00,000 (₹40 Crore) to Vitizen Hotels Limited.
• · Vitizen Hotels Limited is the unlisted material subsidiary with 20+ hotels mainly in Maharashtra and Gujarat.
• · Company's registered office: Units No. 5-8, Tapovan Co-operative Housing Society Ltd., Near Nahur Station, Bhandup West, Mumbai-400078.
• · Statutory Auditors: M/s Chaturvedi Sohan & Co., Chartered Accountants.
• · Internal Auditors: M/s Pipalia Singhal & Associates, Chartered Accountants.

06-08-2026

J.Kumar Infraprojects Limited reported its unaudited standalone financial results for the quarter ended June 30, 2026. Revenue from operations grew 1.9% YoY to ₹1,50,741.83 Lakhs, while profit after tax increased 9.1% YoY to ₹9,781.30 Lakhs. However, sequentially, revenue declined 4.1% from the March 2026 quarter, and profit after tax fell 7.3%. The Board also approved the appointment of M/s. S P M L & Associates as the new Statutory Auditors for a five-year term, subject to shareholder approval.

• · The Board approved the appointment of M/s. S P M L & Associates as the new Statutory Auditors for a five-year term (from the 27th AGM to the 32nd AGM), subject to shareholder approval.
• · The 27th Annual General Meeting is scheduled for Tuesday, September 22, 2026 at 11:00 AM IST.
• · Book closure for the AGM and dividend entitlement is from September 16, 2026 to September 22, 2026.
• · The trading window for designated persons will reopen on August 8, 2026.
• · Total comprehensive income for Q1 FY27 was ₹10,380.90 Lakhs, up 0.4% YoY from ₹10,339.84 Lakhs.
• · Finance costs increased 12.8% YoY to ₹4,325.96 Lakhs in Q1 FY27.

06-08-2026

Aplab Ltd. has issued the Notice for its 61st Annual General Meeting (AGM) and the Annual Report for FY 2025-26. The AGM will be held on August 28, 2026, via video conferencing, with key resolutions including the re-appointment of Managing Director Sanjay N. Mehta, the appointment of Nishith P. Deodhar as Executive Director, and the appointment of Tanvi Paharia Jain as a Non-Executive Non-Independent Director. The filing also notes recent board changes, including the resignation of Chairperson Amrita P. Deodhar and Independent Director Uma Balakrishnan.

• · The Register of Members and Share Transfer Books will be closed from August 22, 2026 to August 28, 2026.
• · Cut-off date for e-voting eligibility is August 21, 2026.
• · Remote e-voting opens on August 25, 2026 at 9:00 AM and closes on August 27, 2026 at 5:00 PM.
• · The company has transferred unclaimed dividends up to FY 1993-94 to the General Revenue Account of the Central Government.
• · Dividends for FY 1994-95 through FY 2008-09 have been transferred to the Investor Education and Protection Fund.
• · The company has two classes of shares listed on BSE: fully paid-up (Scrip Code 517096) and partly paid-up (Scrip Code 890217).

06-08-2026

Aptus Value Housing Finance India Limited held its 17th AGM on August 4, 2026, where all seven resolutions were passed with the requisite majority. While resolutions on routine matters (e.g., adoption of financials, re-appointment of Independent Director, borrowing limits, charge creation, and NCD issuance) received overwhelming support (over 99% in favor), two resolutions relating to the new Aptus ESOP 2026 and extending options to subsidiary employees saw significant opposition from institutional shareholders, with 38.92% voting against. Overall, the voting turnout was 77.88% of outstanding shares.

• · Resolutions 6 and 7 (ESOP-related) faced notable dissent from institutional investors: out of 26,93,73,746 institutional votes polled, 10,48,51,160 (38.92%) were cast against each resolution.
• · Non-institutional shareholders largely supported the ESOP resolutions with 98.93% in favor (only 1.07% against).
• · Promoter and Promoter Group voted 100% in favor across all resolutions.
• · The AGM was held via Video Conferencing, with only 46 shareholders attending virtually.
• · All resolutions were passed on the same date as the AGM (August 4, 2026).

06-08-2026

JSW Holdings Limited reported unaudited standalone profit for Q1 FY27 of ₹2,147.08 Lakhs, up 9.1% from ₹1,967.20 Lakhs in Q1 FY26, driven by higher interest income (₹3,216.45 Lakhs vs ₹2,859.38 Lakhs). However, total comprehensive income swung to a gain of ₹2,23,813.37 Lakhs from a loss of ₹70,118.18 Lakhs in the prior-year quarter, primarily due to a large positive fair value change in equity instruments. Operating expenses rose sharply to ₹567.73 Lakhs from ₹372.87 Lakhs, with employee benefits expense nearly doubling sequentially.

• · The Board meeting commenced at 2:00 PM IST and concluded at 2:35 PM IST on August 6, 2026.
• · The trading window for designated persons will reopen on August 9, 2026.
• · The company reversed an excess provision of ₹26.54 Lakhs related to the Labour Codes during Q4 FY26, which is disclosed as an exceptional item.
• · Consolidated results include the parent's share of net profit of associates of ₹306.49 Lakhs and share of total comprehensive loss of ₹1,846.77 Lakhs for Q1 FY27.
• · Basic EPS for Q1 FY27 stood at ₹19.35 (standalone) vs ₹17.73 in Q1 FY26.
• · Other equity as of March 31, 2026 was ₹31,96,952.64 Lakhs.

06-08-2026

Garware Synthetics Ltd reported a net loss of ₹6.55 Lakh for the quarter ended June 30, 2026, compared to a profit of ₹11.97 Lakh in the same quarter last year, driven by a sharp decline in revenue and higher expenses. Revenue from operations fell 35.4% YoY to ₹168.15 Lakh, while total expenses decreased only 29.6%, resulting in a negative bottom line. The board also approved the appointment of Mr. A G Mehta as Company Secretary and Compliance Officer.

• · Total expenses for Q1 FY27 were ₹175.00 Lakh, down 29.6% from ₹248.57 Lakh in Q1 FY26, but still exceeded revenue, causing the loss.
• · Cost of material consumed rose to ₹118.52 Lakh from ₹129.94 Lakh YoY, a decline of 8.8%, while employee benefit expenses decreased slightly to ₹54.12 Lakh from ₹54.94 Lakh.
• · Finance costs increased sharply to ₹6.40 Lakh from ₹2.29 Lakh YoY, a 179.5% rise.
• · Depreciation and amortization expenses increased to ₹15.21 Lakh from ₹11.02 Lakh YoY, up 38.0%.
• · The company operates in a single business segment: Nylon Bristles, Rods & Tubes.
• · The statutory auditors issued an unmodified review conclusion with no material misstatements noted.

06-08-2026

PTL Enterprises Limited reported its unaudited financial results for the quarter ended June 30, 2026. Revenue from operations remained nearly flat at ₹1,608.31 Lakhs compared to ₹1,608.31 Lakhs in the same quarter last year, while profit after tax declined 5.1% YoY to ₹875.21 Lakhs from ₹922.08 Lakhs. The company's total comprehensive income also decreased 15.7% YoY to ₹2,549.16 Lakhs, driven by lower gains on fair value of equity investments.

• · The company's sole business segment is income from lease of plant to Apollo Tyres Ltd.
• · Other income surged to ₹13.00 Lakhs in Q1 FY27 from ₹10.69 Lakhs in Q1 FY26, a 21.6% increase.
• · Total expenses increased 14.2% YoY to ₹362.47 Lakhs from ₹317.35 Lakhs, driven by a 74.1% jump in other expenses (₹123.39 Lakhs vs ₹70.89 Lakhs).
• · Finance costs declined 13.1% YoY to ₹103.44 Lakhs from ₹118.97 Lakhs.
• · The company reported a gain of ₹1,923.40 Lakhs on fair value of equity investments through OCI in Q1 FY27, compared to a gain of ₹2,194.54 Lakhs in Q1 FY26.
• · The Board meeting commenced at 3:00 PM and concluded at 3:32 PM on August 6, 2026.
• · The statutory auditors issued an unmodified (clean) conclusion on the financial results.

06-08-2026

Sanathan Textiles reported Q1 FY27 results with strong standalone growth: revenue up 8.43% YoY to ₹813.13 Cr, EBITDA up 35.52% YoY to ₹94.93 Cr, and PAT up 37.64% YoY to ₹64.95 Cr. Consolidated revenue surged 79.08% YoY to ₹1,334.74 Cr, driven by higher selling prices and the full contribution from the Punjab facility. However, consolidated PAT declined sharply from ₹40.43 Cr in Q1 FY26 to ₹23.82 Cr, as depreciation rose from ₹11.7 Cr to ₹34.7 Cr and finance costs jumped from ₹4.62 Cr to ₹38.6 Cr due to the commissioning of the Punjab plant. The company achieved 80% capacity utilization at Punjab and completed the expansion of technical textile capacity at Silvassa from 9,000 to 18,000 MTPA.

• · Standalone EBITDA margin improved 233 bps YoY to 11.67% and 72 bps sequentially.
• · Consolidated EBITDA margin was broadly stable sequentially at 8.10% but declined from 9.33% in Q1 FY26.
• · Consolidated PAT margin fell to 1.78% from 5.42% a year ago.
• · Punjab facility contributed ~₹550 Cr revenue and ~₹12 Cr EBITDA in Q1 FY27.
• · Management targets Punjab EBITDA per ton of ~₹30,000 next year.
• · Government waived 11% customs duty on raw cotton imports effective June 1, 2026.
• · Silvassa technical textile capacity doubled to 18,000 MTPA; commercial production imminent.
• · Punjab polymerization capacity utilization at 80%; targeting higher in Q2.
• · Captive 32 MW hybrid wind-solar power to be commissioned in phases.

06-08-2026

Tata Steel reported a resilient Q1 FY2027 performance with consolidated revenues of ₹60,794 crore and EBITDA of ₹9,370 crore, driven by strong India operations. India EBITDA rose 32% YoY to ₹9,900 crore with a per-ton EBITDA of ₹19,162, while the UK and Netherlands faced headwinds from supply chain disruptions and a temporary Direct Sheet Plant shutdown. The company also announced a 4.8 MTPA expansion at NINL and noted that unplanned cost increases of ₹1,200 crore from the West Asia conflict are expected to taper in coming quarters.

• · India business contributed 75% of total crude steel production.
• · Standalone revenue per ton increased by ₹9,212 QoQ, partly offset by cost increase of ₹6,700 per ton due to lower volumes.
• · Material costs up ₹1,330 per ton; conversion costs up ₹5,400 per ton QoQ.
• · NINL EBITDA margin improved from 27% in Q4 to 29% in Q1.
• · UK reduced tariff-free import quotas by 3.3–3.4 million tons effective July 1, with 50% tariff on excess.
• · Netherlands Direct Sheet Plant (20% of production) shut since April; approval for 4-week run from August 5.
• · Tata Steel has ~50% market share in the Indian automotive sector.
• · Digital platforms Aashiyana and DigECA combined GMV ₹2,200 crore, up 61% YoY.
• · Board approved 4.8 MTPA expansion at NINL, taking total capacity to ~6.2 MTPA.
• · Unplanned cost increases of ₹1,200 crore due to West Asia conflict expected to taper.

06-08-2026

Shivalik Bimetal Controls Limited reported standalone revenue of ₹13,180.81 Lakh for Q1 FY27 (quarter ended June 30, 2026), up 12.9% from ₹11,669.53 Lakh in Q1 FY26. Net profit rose 25.9% YoY to ₹2,639.99 Lakh from ₹2,097.33 Lakh. However, the company saw the resignation of its statutory auditor (M/s Arora Gupta & Co.) and its CFO (Mr. Rajeev Ranjan, effective Oct 31, 2026), while appointing M/s Walker Chandiok & Co LLP as the new statutory auditor and re-appointing Mr. Kabir Ghumman as Managing Director by rotation.

• · Revenue from operations for Q1 FY27 was ₹13,180.81 Lakh vs ₹11,670.94 Lakh in the preceding quarter (Q4 FY26), a sequential increase of 12.9%.
• · Net profit for Q1 FY27 was ₹2,639.99 Lakh vs ₹2,037.95 Lakh in Q4 FY26, a sequential increase of 29.5%.
• · Cost of materials consumed increased to ₹8,519.86 Lakh in Q1 FY27 from ₹6,446.85 Lakh in Q1 FY26, a 32.2% YoY increase.
• · Employee benefit expense rose to ₹1,279.34 Lakh in Q1 FY27 from ₹1,011.05 Lakh in Q1 FY26, a 26.5% YoY increase.
• · Finance costs increased to ₹91.69 Lakh in Q1 FY27 from ₹75.76 Lakh in Q1 FY26, a 21.0% YoY increase.
• · Depreciation and amortisation expense rose to ₹335.80 Lakh in Q1 FY27 from ₹275.07 Lakh in Q1 FY26, a 22.1% YoY increase.
• · Other expenses increased to ₹1,878.74 Lakh in Q1 FY27 from ₹1,634.16 Lakh in Q1 FY26, a 15.0% YoY increase.
• · Exceptional items of ₹25.75 Lakh (credit) were recorded in Q1 FY27 vs nil in Q1 FY26.
• · The company reported an exceptional item of ₹79.06 Lakh in FY26 (full year).
• · The Board approved the re-appointment of M/s Amit Saxena and Associates as scrutinizer for e-voting at the AGM.
• · The Board reconstituted several committees including Audit Committee, Stakeholder Relationship Committee, CSR Committee, Nomination and Remuneration Committee, and Risk Management Committee.
• · The resignation of statutory auditor M/s Arora Gupta & Co. was noted and accepted; M/s Walker Chandiok & Co LLP appointed as new statutory auditor for a 5-year term subject to shareholder approval.
• · M/s Malik S. & Co. appointed as Tax Auditors for FY 2026-27.
• · The Board approved the Director's Report, Corporate Governance Report, Business Responsibility and Sustainability Report, and Management Discussion and Analysis for FY 2025-26.

06-08-2026

Chandra Bhagat Pharma Limited has filed its Annual Report for FY2025-26 and convened its 23rd Annual General Meeting for September 1, 2026. The company proposes to increase its authorized share capital from ₹8.5 Cr to ₹15 Cr and to issue up to 66,00,000 convertible warrants on a preferential basis to promoters and non-promoters at ₹44 per warrant, aggregating up to ₹29.04 Cr. The filing does not disclose financial performance figures, so no period-over-period comparison is possible.

• · The 23rd AGM is scheduled for Tuesday, September 1, 2026 at 4:00 PM IST at the registered office in Mumbai.
• · The annual report is available on the company's website (www.cbcpharma.com) and BSE website (www.bseindia.com).
• · The warrant issue price is ₹44 per warrant (face value ₹10 + premium ₹34).
• · Warrant holders must pay at least 25% of the issue price upfront; the remaining 75% is due upon conversion.
• · Warrants have a conversion period of 18 months from allotment; unexercised warrants will lapse and the upfront payment will be forfeited.
• · The relevant date for determining the minimum issue price under SEBI ICDR Regulations is July 31, 2026.
• · The company's CIN is L24230MH2003PLC139534 and its equity shares are listed on the BSE SME platform (Scrip Code: 542934).

06-08-2026

Crompton Greaves Consumer Electricals reported consolidated revenue from operations of ₹2,235.02 Cr for Q1 FY27 (June 2026), up 11.8% YoY from ₹1,998.38 Cr in Q1 FY26. Net profit attributable to owners rose 14.9% YoY to ₹140.48 Cr from ₹122.29 Cr. However, sequentially (vs Q4 FY26), revenue declined 2.1% and profit before exceptional items fell 17.7%, indicating a seasonal slowdown. The Lighting Products segment showed a sequential revenue decline of 14.8%, while Butterfly Products revenue was nearly flat sequentially.

• · The Board Meeting commenced at 10:10 AM and concluded at 4:20 PM on August 6, 2026.
• · Paid-up equity share capital stood at ₹128.78 Cr (face value ₹2 each).
• · Basic and diluted EPS for Q1 FY27 were ₹2.18 (not annualised), compared to ₹1.90 in Q1 FY26.
• · Total comprehensive income for the quarter was ₹141.81 Cr, up from ₹123.86 Cr YoY.
• · Finance costs decreased to ₹9.70 Cr in Q1 FY27 from ₹14.61 Cr in Q1 FY26, a 33.6% reduction.
• · The company had total assets of ₹5,965.19 Cr as of June 30, 2026, down from ₹6,082.55 Cr as of March 31, 2026.
• · The standalone financial results were also reviewed and approved in the same board meeting.

06-08-2026

Hindustan Construction Company Ltd. (HCC) has fully utilized the ₹999.99 crore raised via its Rights Issue (Dec 2025) as of Q1 FY27, with all proceeds deployed in line with the stated objects: repayment of borrowings (₹625 Cr), investment in JV Prolific Resolution (₹200 Cr), working capital (₹100 Cr), general corporate purposes (₹35.54 Cr), and issue expenses (₹39.45 Cr). However, the monitoring agency noted a delay of 76 days in the utilization of funds for general corporate purposes and a 72-day delay for augmenting working capital, though no material deviation from the objects was reported.

• · The Rights Issue period was December 12-17, 2025.
• · Monitoring Agency Agreement dated November 26, 2025.
• · No deviation from the objects of the issue was observed.
• · All government/statutory approvals related to the objects were not required.
• · The company fully utilized ₹35.54 crore towards General Corporate Purposes, including ₹1.02 crore of unutilized issue expenses.
• · Issue expenses were lower than budgeted, with unutilized amount spent towards GCP.
• · Chartered Accountant certificate from Mukund M. Chitale & Co. dated July 27, 2026, was relied upon.

06-08-2026

Granules India Limited held its 35th Annual General Meeting on August 6, 2026 via video conferencing, with 67 members attending. All three ordinary resolutions—adoption of audited financial statements for FY 2025-26, declaration of a final dividend of ₹1.75 per equity share, and re-appointment of Ms. Priyanka Chigurupati—were passed with overwhelming majority (over 99.6% in favor). The meeting concluded in just over an hour, reflecting routine governance with no contentious items.

• · The AGM commenced at 11:30 AM IST and concluded at 12:34 PM IST, lasting 64 minutes.
• · Remote e-voting period was from August 3, 2026 (9:00 AM IST) to August 5, 2026 (5:00 PM IST).
• · Record date for voting eligibility was July 30, 2026.
• · Total votes cast on Resolution 1 (financial statements): 176,378,532; in favor: 176,105,661 (99.9979%); against: 3,663; abstentions: 269,208.
• · Total votes cast on Resolution 2 (dividend): 176,378,532; in favor: 176,371,423 (99.9979%); against: 3,681; abstentions: 3,428.
• · Total votes cast on Resolution 3 (re-appointment of Priyanka Chigurupati): 176,378,532; in favor: 175,826,229 (99.6892%); against: 548,166; abstentions: 4,137.
• · All resolutions were declared passed by requisite majority.
• · The scrutinizer's report was prepared by Dhanunjaya Kumar Alla, Partner at Dhanunjaya & Haranath, Chartered Accountants.

06-08-2026

GHCL Limited reported Q1 FY27 revenue of INR798 crore, down from INR823 crore YoY, while EBITDA improved to INR233 crore (margin 29.1%) from INR225 crore (27.3%) in the same quarter last year, driven by cost optimization and lower input costs. However, management cautioned that elevated margins are transient due to rising energy costs and a weak global soda ash market, with demand soft and imports increasing. The Vacuum Salt and Bromine projects are expected to commence commercial production in Q2 FY27, contributing INR150-160 crore revenue at 40-45% EBITDA margins at optimal utilization, while the Greenfield soda ash project faces land acquisition delays.

• · Net cash surplus exceeded INR1,000 Cr at end of Q1 FY27.
• · Cash profit after tax was INR216 Cr; of this, INR36 Cr spent on capex, INR109 Cr on dividends, INR6 Cr on debt repayment, and INR116 Cr on working capital and other items.
• · Exceptional item of INR40 Cr (net of taxes) from ESOS Trust settlement boosted PAT to INR191 Cr.
• · Dividend payout policy: approximately 25% payout ratio; Board to consider further shareholder rewards.
• · Greenfield soda ash project delayed primarily due to land acquisition issues; no timeline guidance provided.
• · No other major capacity additions announced by competitors in India.
• · Imports increased sequentially but declined marginally YoY.
• · Management expects margins to moderate from current levels and revert to normalized trend; advises assessing margins on an annual basis.
• · Global soda ash market: supply exceeds demand, Chinese inventories high, early signs of capacity rationalization (maintenance closures) but meaningful supply reduction still distant.
• · Collapse of U.S.-Iran ceasefire introduced renewed volatility in energy markets and supply chains.

06-08-2026

Shri Vasuprada Plantations Limited (formerly Joonktollee Tea & Industries Ltd.) has issued the Notice for its 152nd Annual General Meeting (AGM) to be held via video conferencing on August 31, 2026 at 11:30 AM IST. The meeting will consider the adoption of audited standalone and consolidated financial statements for FY2025-26, the re-appointment of Mr. Hemant Bangur as a director retiring by rotation, and ratification of cost auditors' remuneration of ₹1,50,000 for FY2026-27. The notice is being sent electronically and the register of members will be closed from August 25 to August 31, 2026.

• · The AGM will be conducted entirely through Video Conferencing / Other Audio Visual Means, dispensing with physical attendance of members.
• · Proxy facility is not available for this AGM.
• · The register of members and share transfer books will remain closed from August 25, 2026 to August 31, 2026.
• · Dividends on 6% Non-Convertible Redeemable Preference Shares have remained unpaid for 3 years, granting those preference shareholders voting rights on all resolutions.
• · The company has transferred all shares where dividend remained unpaid/unclaimed for seven consecutive years to the IEPF Authority during FY2025-26.
• · Remote e-voting will be provided by CDSL; cut-off date for voting eligibility is August 24, 2026.

06-08-2026

Sun Pharma reported Q1 FY27 consolidated sales of INR151,836 million, up 10.1% YoY, driven by 16% growth in India formulations and 12.8% growth in global innovative medicines. However, U.S. sales declined 9.7% YoY to USD427 million due to Lenalidomide erosion and generic competition, and EBITDA margins slipped to 28.9% from a year ago (adjusted higher excluding prior-year Lenalidomide benefit). The Organon acquisition received shareholder approval and is on track to close by early 2027, with integration planning underway.

• · Rest of World formulations revenue was marginally lower YoY at USD218 million.
• · Forex gain for Q1 FY27 was INR1,220 million, lower than Q1 FY26.
• · Exceptional items include INR1,617 million charge for Organon acquisition costs; additional charges expected in subsequent quarters.
• · Effective tax rate rose to 27.8% from 24.3% in Q1 FY26 due to exhaustion of lower India tax rate.
• · Innovative R&D accounted for 30% of total R&D spend of INR8,264 million.
• · Philogen has resubmitted Nidlegy for marketing authorization in Europe.
• · Sun Pharma is the only company in India offering semaglutide auto-injector.
• · Leqselvi surpassed 1,000 prescribers in June 2026 and delivered strongest month since launch.
• · Unloxcyt shows month-over-month growth as more cancer centers add it to formularies.
• · Sun Pharma holds 8.5% market share in the Indian pharmaceutical market (MAT June 2026), up from 8.2%.
• · Sun Pharma's volume growth of 5.4% compares favorably to IPM volume growth of 2%.
• · The company launched five new products in India and five generic products in the U.S. during Q1 FY27.

06-08-2026

Indraprastha Medical Corporation Limited (Indraprastha Apollo Hospitals) reported unaudited financial results for Q1 FY27 (quarter ended June 30, 2026), with total income rising 11.5% YoY to ₹414.57 Cr and profit after tax increasing 8.5% YoY to ₹55.85 Cr. However, sequentially, total income grew 11.4% from the March 2026 quarter, while PAT rose 33.9% from ₹41.70 Cr, indicating strong operational performance. The Board also approved the re-appointment of cost auditors and fixed September 18, 2026 as the record date for the upcoming AGM and dividend.

• · The Board approved the re-appointment of M/s Devarajan Swaminathan and Co. as Cost Auditors for FY 2026-27.
• · Record date for dividend and AGM is fixed as September 18, 2026.
• · The 38th Annual General Meeting will be held on September 24, 2026 via video conferencing.
• · The company operates in a single segment: Healthcare, and has no subsidiaries, associates, or joint ventures.
• · Total comprehensive income for Q1 FY27 was ₹58.10 Cr, up from ₹55.94 Cr in Q1 FY26 (YoY growth of 3.9%).
• · Employee benefits expense increased 12.3% YoY to ₹72.96 Cr, while professional charges to doctors rose 13.6% YoY to ₹111.15 Cr.
• · Finance costs remained relatively stable at ₹1.65 Cr (up 5.8% YoY from ₹1.56 Cr).
• · Other comprehensive income (net of tax) was ₹2.25 Cr in Q1 FY27 vs ₹4.48 Cr in Q1 FY26, a decline of 49.8% YoY.

06-08-2026

Yasho Industries Limited held its 40th Annual General Meeting on August 6, 2026, via video conferencing, where all eight resolutions were passed, including the adoption of audited financial statements for FY2025-26, declaration of a dividend, re-appointment of directors, and approval of revised remuneration for key managerial personnel. The meeting lasted 25 minutes and was chaired by Managing Director Parag Jhaveri, who highlighted business performance and growth plans. No specific financial figures or performance metrics were disclosed in the filing, limiting the ability to assess sentiment.

• · The AGM was conducted through Video Conferencing / Other Audio Visual Means.
• · All directors except Mrs. Sudha Navandar were present.
• · The meeting commenced at 04:00 PM IST and concluded at 04:25 PM IST.
• · Resolutions included adoption of standalone and consolidated financial statements, dividend declaration, re-appointment of directors, ratification of cost auditor remuneration, and revision of remuneration for Managing Director and Whole Time Director.
• · Remote e-voting results and Scrutinizer's Report to be announced within 2 working days.